Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the novel one-step preparation and resolution of 2-acylamino-3-biphenylpropionic acid. A cost-effective, high-purity route for API manufacturing.
Patent CN101935309A reveals a novel Ezetimibe synthesis using indeno-oxazole auxiliaries, offering 99.97% ee and scalable manufacturing for reliable API intermediate supply chains.
Patent CN108864252B reveals a scalable liquid-phase synthesis for NRX-1074, offering high purity without preparative HPLC for reliable API intermediate supply.
Novel resolution method using ethyl acetate and ethanol mixtures ensures high optical purity and yield for scalable antidepressant intermediate production.
Novel quinine-based resolution method for (S)-oxiracetam ensures high optical purity and scalable production for pharmaceutical supply chains.
Novel chiral resolution method using aspartic acid eliminates chromatography, offering high purity and scalable production for pharmaceutical intermediates.
Patent CN103497145B details a scalable chiral resolution process for donepezil intermediates, offering high purity and cost-effective supply chain solutions for pharmaceutical manufacturing.
Novel synthesis route for tetrahydroprotoberberine compounds via Bischler-Napieralski reaction. Enables batch production of l-SPD and d-SPD with high optical purity.
Patent CN101891647A details a novel Ubenimex preparation using L-lysine resolution and EDCI/HOAt coupling, ensuring >99.5% purity and robust supply chain reliability.
Patent CN108047125A details a low-cost synthesis route for Argatroban intermediates. Achieve high purity and scalable supply chain reliability with optimized manufacturing processes.
Patent CN109761984B details a novel ruthenium-catalyzed asymmetric hydrogen transfer method for synthesizing chiral purine nucleosides with high enantioselectivity and mild conditions.
Patent CN112680497A reveals enzymatic splitting for high-purity Corey lactone. Achieve significant cost reduction in API intermediate manufacturing and supply reliability.
Novel three-step process for Ritlecitinib Tosylate reduces chromatography steps. Ensures high purity and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN111848322B details a mild resolution method for axially chiral oxindole styrenes using chiral phosphoric acid, offering high enantioselectivity for pharma applications.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Patent CN109134351B details a novel synthesis of S-3-(4-aminophenyl)piperidine with >99% ee, offering cost-effective scalability for PARP inhibitor manufacturing.
Patent CN112675920B reveals a novel Ruthenium catalyst for efficient chiral alcohol synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable production methods.
Patent CN114315609A discloses a novel 3-step process for cis-2-aminocyclohexanol from cyclohexene, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN112675920B reveals a novel monochiral ruthenium catalyst enabling efficient asymmetric hydrogenation and kinetic resolution for high-purity pharmaceutical intermediates.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.